Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 2.48% is 30% above its 1-year average of 1.91%, near the high end of its 1-year range (1.50%–2.48%).
As of 2026-10-06T20:01:03.724Z.
Calculation as of: 2026-10-06T20:01:03.724Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47b7d046e53ba400f53df530976eb059ace8f079140d97e9bcfa36b682aba175
EARNINGS YIELD
2.48%
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.91%
median of 187 covered companies
CURRENT VS SECTOR MEDIAN
-36.57%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$439.55M
Earnings Yield
2.48%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$443.27M
Earnings Yield
N/A
TTM Avg
49.38%
3Y Avg
49.38%
5Y Avg
49.38%
Market Cap
$434.84M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$445.71M
Earnings Yield
N/A
TTM Avg
1.29%
3Y Avg
1.29%
5Y Avg
1.29%
Market Cap
$425.51M
Earnings Yield
N/A
TTM Avg
0.52%
3Y Avg
0.52%
5Y Avg
0.52%
Market Cap
$424.08M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $439.55M | 2.48% | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $443.27M | N/A | 49.38% | 49.38% | 49.38% |
| NeuroPace, Inc. (NPCE)vs › | $435.38M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $434.84M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | N/A | 1.29% | 1.29% | 1.29% |
| NRC Health (NRC)vs › | $453.10M | 1.26% | 3.15% | 4.59% | 4.10% |
| NeoGenomics, Inc. (NEO)vs › | $425.64M | N/A | 4.67% | 2.17% | 1.96% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $425.51M | N/A | 0.52% | 0.52% | 0.52% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $424.08M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $423.84M | N/A | N/A | N/A | N/A |
Earnings Yield
2.48%
EPS ÷ Price
P/E Ratio
40.3
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-10-05 | 2.42% |
| 2026-10-02 | 2.44% |
| 2026-10-01 | 2.39% |
| 2026-09-30 | 2.34% |
| 2026-09-29 | 2.34% |
| 2026-09-28 | 2.33% |
| 2026-09-25 | 2.32% |
| 2026-09-24 | 2.32% |
| 2026-09-23 | 2.29% |
| 2026-09-22 | 2.16% |
| 2026-09-21 | 2.16% |
| 2026-09-18 | 2.20% |
| 2026-09-17 | 2.17% |
| 2026-09-16 | 2.16% |
| 2026-09-15 | 2.11% |
| 2026-09-14 | 1.90% |
| 2026-09-11 | 1.85% |
| 2026-09-10 | 1.81% |
| 2026-09-09 | 1.67% |
| 2026-09-08 | 1.56% |
| 2026-09-04 | 1.50% |
| 2026-09-03 | 1.52% |
| 2026-09-02 | 1.50% |
| 2026-09-01 | 1.56% |
| 2026-08-31 | 1.64% |
| 2026-08-28 | 1.61% |
| 2026-08-27 | 1.58% |
| 2026-08-26 | 1.55% |
| 2026-08-25 | 1.56% |
| 2026-08-24 | 1.56% |
| 2026-08-21 | 1.60% |
| 2026-08-20 | 1.64% |
| 2026-08-19 | 1.63% |
| 2026-08-18 | 1.71% |
| 2026-08-17 | 1.83% |
| 2026-08-14 | 1.67% |
